An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia

被引:5
|
作者
Dursun, S [1 ]
机构
[1] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England
关键词
D O I
10.1177/0269881105057347
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:3 / 4
页数:2
相关论文
共 50 条
  • [1] Long-acting injectable risperidone: Efficacy and safety of the first long-acting atypical antipsychotic
    Kane, JM
    Eerdekens, M
    Lindenmayer, JP
    Keith, SJ
    Lesem, M
    Karcher, K
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (06): : 1125 - 1132
  • [2] Long-acting injectable atypical antipsychotic: a relapse risk study
    Dejean, C.
    Chabaud, F.
    Pigeot, E.
    Bouet, R.
    Richard, D.
    Levy-Chavagnat, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 96 - 97
  • [3] Long-acting, injectable risperidone - the first long-acting, atypical antipsychotic - improves quality of life
    Nasrallah, H
    Duchesne, I
    Mehnert, A
    Janagap, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S282
  • [4] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Mohamed, Somaia
    Rosenheck, Robert
    Harpaz-Rotem, Ilan
    Leslie, Douglas
    Sernyak, Michael J.
    PSYCHIATRIC QUARTERLY, 2009, 80 (04) : 241 - 249
  • [5] Duration of Pharmacotherapy with Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
    Somaia Mohamed
    Robert Rosenheck
    Ilan Harpaz-Rotem
    Douglas Leslie
    Michael J. Sernyak
    Psychiatric Quarterly, 2009, 80 : 241 - 249
  • [6] Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
    Eun Ji Park
    Sarmila Amatya
    Myung Sun Kim
    Jong Hoon Park
    Eunyoung Seol
    Heeyong Lee
    Young-Hee Shin
    Dong Hee Na
    Archives of Pharmacal Research, 2013, 36 : 651 - 659
  • [7] Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia
    Park, Eun Ji
    Amatya, Sarmila
    Kim, Myung Sun
    Park, Jong Hoon
    Seol, Eunyoung
    Lee, Heeyong
    Shin, Young-Hee
    Na, Dong Hee
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (06) : 651 - 659
  • [8] Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study
    Fortea, Adriana
    Ilzarbe, Daniel
    Espinosa, Laura
    Solerdelcoll, Mireia
    de Castro, Clara
    Oriolo, Giovanni
    Sugranyes, Gisela
    Baeza, Inmaculada
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (04) : 252 - 257
  • [9] Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidone
    Martin, SD
    Libretto, SE
    Pratt, DJ
    Brewin, JS
    Huq, ZU
    Saleh, BT
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (04) : 298 - 305
  • [10] A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia
    Bhanji, NH
    Chouinard, G
    Margolese, HC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 (02) : 87 - 92